Haleon HLN
NYSE HLN
$9.86 -0.01 (-0.05%)
At close: Aug 20, 2026 · 10:59 AM UTC

Haleon (HLN) Cash & Current Investments (2021 - 2026)

Haleon's (HLN) quarterly Cash & Current Investments came in at $963.3 million in Q2 2026, down 48.72% on a QoQ basis from $1.9 billion in Q4 2025.

Haleon (HLN) Cash & Current Investments (2021 - 2026) Analysis & Trends

Haleon (HLN) has 6 years of Cash & Current Investments data on file, last reported at $963.3 million in Q2 2026.

  • Quarterly Cash & Current Investments changed N/A year-over-year to $963.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $963.3 million (changed N/A YoY) and the FY2025 annual result came in at $1.9 billion, down 38.7% from the prior year.
  • Cash & Current Investments eased to $963.3 million in Q2 2026, from $1.9 billion in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $3.1 billion in Q4 2024 to a low of $381.7 million in Q2 2023.
  • A 5-year average of $1.4 billion and a median of $1.1 billion in 2023 frame the typical range for Cash & Current Investments.
  • Annual changes were most pronounced in 2023 — Cash & Current Investments tumbled 79.52% — and 2024, when it surged 130.67%.
  • Tracing HLN's Cash & Current Investments over 5 years: stood at $860.9 million in 2022, then jumped by 53.82% to $1.3 billion in 2023, then surged by 130.67% to $3.1 billion in 2024, then tumbled by 38.51% to $1.9 billion in 2025, then slumped by 48.72% to $963.3 million in 2026.
  • The last three Cash & Current Investments figures came in at $963.3 million (Q2 2026), $1.9 billion (Q4 2025), and $3.1 billion (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Haleon 43.81 Bn 42.84 Bn - 963.33 Mn
2 Teva Pharmaceutical Industries 43.29 Bn 39.63 Bn 2.15 Bn 3.66 Bn
3 Zoetis 31.59 Bn 29.91 Bn 1.05 Bn 1.68 Bn
4 Takeda Pharmaceutical 28.67 Bn 22.88 Bn 5.10 Bn 5.80 Bn
5 United Therapeutics 22.24 Bn 19.58 Bn 683.80 Mn 2.66 Bn
6 Viatris 18.79 Bn 17.91 Bn 1.46 Bn 886.50 Mn
7 Neurocrine Biosciences 15.71 Bn 15.32 Bn 935.80 Mn 389.80 Mn
8 Elanco Animal Health 12.09 Bn 11.56 Bn 798.00 Mn 530.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn - 164.00 Mn
10 Alkermes 8.19 Bn 7.53 Bn 397.90 Mn 656.58 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 963.33 Mn
Dec 31, 2025 1.88 Bn
Dec 31, 2024 3.05 Bn
Jun 30, 2024 541.49 Mn
Dec 31, 2023 1.32 Bn
Jun 30, 2023 381.67 Mn
Dec 31, 2022 860.93 Mn
Jun 30, 2022 1.86 Bn
Dec 31, 2021 564.82 Mn